Executive Summary
This digest of 40 filings reveals a period of significant leadership transition across US equities, with 15+ officer and director changes announced on a single day (August 11, 2026).
The most critical developments include a major CEO succession at ConocoPhillips (a 42-year veteran retiring), a pending merger vote at Apogee Therapeutics (shareholders rejected advisory compensation despite approving the AbbVie deal), and a CFO departure at Kilroy Realty creating interim uncertainty. Period-over-period data from the enriched filings shows a stark divergence: industrial and energy companies (Smart Sand, ConocoPhillips) are demonstrating strong operational momentum, while healthcare and tech firms (Aura Biosciences, Mineralys Therapeutics, Inuvo) are reporting widening losses and restructuring. A notable pattern is the prevalence of 'mixed' sentiment in filings with both positive catalysts (e.g., Phase 3 trial enrollment, new product launches) and negative financials (e.g., net losses, cash burn), suggesting the market is pricing in binary outcomes. Insider activity is limited in this batch, but the compensation-linked equity awards at Imunon and Lee Enterprises signal management alignment. The overarching theme is a market in transition, with companies aggressively reshaping leadership and capital structures to navigate a challenging macro environment.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from August 10, 2026.
Investment Signals (12)
- Smart Sand ↓ (BULLISH)▲
Record Q2 revenue of $115.1M (+34% YoY, +24% QoQ), swung to net income of $10.2M from -$3.9M loss in Q1, and guided 10-20% sales volume growth for FY2026. CFO transition planned but orderly.
- ConocoPhillips ↓ (BULLISH)▲
Planned CEO succession from Ryan Lance (42-year veteran) to Andy O'Brien (current CFO) is a smooth, well-communicated transition. O'Brien's deep internal knowledge and CFO background suggest strategic continuity.
-
Merger with AbbVie approved by shareholders (46.5M for vs 3.9K against), but the non-binding advisory compensation proposal was rejected (19.3M for vs 27.1M against). This signals potential shareholder dissent on deal terms, but does not block the merger. [MIXED/BULLISH for merger completion]
-
PDUFA target date for lorundrostat is December 22, 2026. The company eliminated royalty obligations via a $200M upfront payment, raised $150M in equity, and secured a $500M term loan. Net loss widened to $241.1M (vs $43.3M) due to the one-time payment, but balance sheet is strong ($667.9M assets). [BULLISH on catalyst]
-
Q2 net sales up 14% to $23.9B, but net loss of $102M vs income of $528M YoY. Leverage increased to 3.1x from 2.27x. Beef North America EBITDA improved but remains negative. Mixed signals: strong top-line growth but margin compression and rising debt. [BEARISH on profitability]
-
Net loss widened to $45.6M (from $27.0M YoY), but Phase 3 CoMpass trial fully enrolled (108 patients, exceeding target). Topline data expected 2H 2027. Cash runway extended into 1H 2029 via 20% workforce reduction. High cash burn but clear catalyst path. [MIXED/BULLISH on pipeline]
- Inuvo ↓ (BEARISH)▲
Total net revenue fell 67% to $7.5M due to 80% decline in Legacy Search, but Audience Modeling revenue grew 19% YoY. Net loss widened to $4.0M. Company raised ~$13M in financing but cash fell to $886K. High risk of dilution/cash crunch.
- Group 1 Automotive ↓ (BULLISH)▲
Appointed David C. Kimbell (former Ulta Beauty CEO) to board. During his tenure at Ulta, revenue grew from $6.2B to $11.3B. This signals a strategic focus on digital transformation and retail excellence.
- Lee Enterprises ↓ (BULLISH)▲
Approved one-time transition equity awards for CEO ($1.75M) and CFO ($900K) with performance metrics tied to stock price and Adjusted EBITDA. New LTIP framework targets 300% of base for CEO. Strong alignment with shareholder value creation.
- Imunon ↓ (BULLISH)▲
Executives elect to receive salary in stock (CEO up to 50%, Chairman up to 100%, CMO up to 40%). This is a strong signal of insider confidence and alignment with shareholders.
- B&G Foods ↓ (BEARISH)▲
CEO retirement announced, but successor identity withheld. This creates uncertainty around strategic direction, especially given ongoing headwinds (supply chain, inflation, tariffs).
- Radian Group ↓ (BULLISH)▲
Appointed Barry C. McCarthy (Deluxe Corp CEO) to board. His payments/fintech expertise aligns with Radian's evolution as a multi-line insurer. Signals potential for tech-driven growth.
Risk Flags (10)
- Aura Biosciences↓ [HIGH RISK]▼
Net loss widened 69% YoY ($45.6M vs $27.0M), driven by increased R&D and G&A. Cash runway extended only through 1H 2029 despite 20% workforce reduction. High cash burn rate is a concern.
- Inuvo↓ [HIGH RISK]▼
Cash and equivalents fell to just $886K despite raising ~$13M in financing. Net loss widened to $4.0M. With total revenue down 67%, the company faces a high risk of needing further dilutive financing.
- JBS N.V.↓ [HIGH RISK]▼
Leverage increased to 3.1x from 2.27x YoY. Net loss of $102M vs income of $528M. Poultry margins declining and higher cattle costs are compressing margins. Debt levels are elevated.
- Mineralys Therapeutics↓ [HIGH RISK]▼
Net loss per share widened to $2.85 from $0.66 YoY, driven by a $200M upfront payment. While the balance sheet is strong, the company is pre-revenue and dependent on FDA approval (PDUFA Dec 22, 2026). Failure would be catastrophic.
- Kilroy Realty↓ [MEDIUM RISK]▼
CFO departure effective immediately, with interim CFO appointed. Stabilized portfolio occupancy at 77.0% and leased at 81.5% are below pre-pandemic levels. Leadership uncertainty in a challenged office sector is a red flag.
- B&G Foods↓ [MEDIUM RISK]▼
CEO succession plan is opaque—successor identity withheld. The company faces ongoing industry headwinds (supply chain disruption, price inflation, tariffs). Lack of clear leadership direction is a risk.
- Comscore↓ [MEDIUM RISK]▼
8-K filing includes Item 2.05 (exit/disposal costs) and Item 5.02 (officer change), suggesting a restructuring tied to leadership transition. No specific names or financial figures disclosed, raising governance concerns.
- SES AI Corp↓ [MEDIUM RISK]▼
8-K includes Item 5.02 (departure of directors or officers) but no name or details provided. Combined with lack of financial disclosure, this could indicate undisclosed governance issues.
- CVRx↓ [MEDIUM RISK]▼
Chief Revenue Officer departed immediately due to 'revised commercial outlook and need to improve execution.' This signals ongoing sales performance challenges.
- Blend Labs↓ [LOW RISK]▼
Principal accounting officer resigned to 'pursue another opportunity.' Interim replacement is not receiving additional compensation, which may indicate a lack of commitment to the role.
Opportunities (10)
- Mineralys Therapeutics↓ (OPPORTUNITY)◆
PDUFA date December 22, 2026 for lorundrostat. The company has eliminated royalty obligations and secured $650M in financing. If approved, the stock could re-rate significantly.
- Smart Sand↓ (OPPORTUNITY)◆
Record Q2 revenue (+34% YoY), swung to profitability, and guided 10-20% volume growth for FY2026. Free cash flow expected positive for full year. Trading at a discount to peers given the strong operational turnaround.
- Aura Biosciences↓ (OPPORTUNITY)◆
Phase 3 CoMpass trial fully enrolled (108 patients, exceeding target), topline data expected 2H 2027. Cash runway extended into 1H 2029. If data is positive, the stock could have significant upside.
- Group 1 Automotive↓ (OPPORTUNITY)◆
Appointment of David Kimbell (former Ulta Beauty CEO) to board signals a focus on digital transformation and retail excellence. His track record of driving revenue growth from $6.2B to $11.3B at Ulta is a strong credential.
- Lee Enterprises↓ (OPPORTUNITY)◆
New CEO and CFO compensation tied 50% to stock price performance and 50% to Adjusted EBITDA. This creates strong alignment with shareholders. The transition awards are one-time, but the LTIP framework is performance-based.
- Imunon↓ (OPPORTUNITY)◆
Executives taking salary in stock (CEO up to 50%, Chairman up to 100%) is a powerful insider confidence signal. This is rare and suggests management believes the stock is undervalued.
- ConocoPhillips↓ (OPPORTUNITY)◆
Smooth CEO succession with deep internal candidate. O'Brien's CFO background suggests continued financial discipline. The transitional role for Lance as Executive Chair ensures continuity.
- Radian Group↓ (OPPORTUNITY)◆
Appointment of Barry McCarthy (Deluxe Corp CEO) with payments/fintech expertise could accelerate Radian's evolution into a tech-enabled insurer. His nearly four decades of experience are a strong addition.
- Apogee Therapeutics↓ (OPPORTUNITY)◆
Merger with AbbVie is proceeding despite shareholder dissent on compensation. The deal is likely to close, providing a near-term cash-out opportunity for shareholders.
- WEC Energy Group↓ (OPPORTUNITY)◆
Appointment of Caroline Garcia as VP and Controller brings Big 4 (KPMG) and utility (TXNM Energy) experience. Her CPA background strengthens financial reporting.
Sector Themes (6)
- Energy/Industrial Leadership Stability◆
ConocoPhillips and Smart Sand both demonstrate orderly leadership transitions with deep internal candidates. This contrasts with the broader market trend of abrupt departures. Implication: Investors should favor companies with clear succession plans.
- Healthcare Cash Burn vs. Catalyst◆
Aura Biosciences and Mineralys Therapeutics both show widening net losses but have clear near-term catalysts (Phase 3 data, PDUFA date). The market is pricing in binary outcomes. Implication: High risk/reward opportunities exist for investors with a catalyst-driven approach.
- Board Refreshment with Fintech/Retail Expertise◆
Multiple companies (Radian, Group 1, Hartford, ManpowerGroup) are adding board members with deep experience in payments, digital transformation, and retail. Implication: Companies are prioritizing tech-enabled growth and customer experience.
- Compensation Alignment via Equity◆
Lee Enterprises and Imunon are using performance-based equity awards and salary-for-stock swaps to align management with shareholders. Implication: This is a positive signal for governance and long-term value creation.
- Restructuring and Cost-Cutting◆
Comscore, Aura Biosciences, and Thryv Holdings are all undergoing restructuring (exit activities, workforce reductions, revised incentive plans). Implication: These actions may improve margins but signal underlying operational challenges.
- M&A Activity Creating Leadership Gaps◆
Apogee Therapeutics (merger with AbbVie) and Lee Enterprises (post-transaction) are seeing entire boards resign or new leadership teams formed. Implication: M&A creates both opportunities and risks as new teams integrate.
Watch List (8)
-
PDUFA target date for lorundrostat is December 22, 2026. Watch for FDA advisory committee meeting and any pre-approval inspection issues.
-
Phase 3 CoMpass trial topline data expected 2H 2027. Monitor for any interim data releases or safety signals.
-
CEO succession effective September 1, 2026. Watch for Q3 earnings call to hear new CEO's strategic vision.
-
CFO search underway with Russell Reynolds. Monitor for appointment of permanent CFO and any impact on 2026 guidance.
-
Successor CEO announcement expected shortly. Watch for identity and strategic direction, especially regarding portfolio reshaping.
-
CFO transition effective January 1, 2027. Monitor Q3 and Q4 results for continued operational momentum and free cash flow generation.
-
Merger closing timeline. Watch for any shareholder lawsuits or regulatory delays despite the approved vote.
-
Leverage at 3.1x and net loss in Q2. Watch for Q3 results and any debt reduction plans or asset sales.
Filing Analyses
(40)
11-08-2026
Comscore filed an 8-K on August 11, 2026, disclosing officer changes under Item 5.02, along with cost-related exit activities (Item 2.05), Regulation FD disclosure (Item 7.01), and financial exhibits (Item 9.01). The filing indicates a leadership transition and associated restructuring costs, but specific names, titles, reasons, and financial figures are not disclosed in the provided metadata. The absence of quantitative details limits the ability to assess materiality or market impact.
- · Filing includes Item 2.05 (exit/disposal costs) and Item 5.02 (officer change), suggesting a restructuring event tied to leadership transition.
- · Item 7.01 (Regulation FD) indicates the company made a selective disclosure, possibly related to the officer change or exit activities.
- · No specific names, titles, effective dates, or financial amounts are provided in the available data.
11-08-2026
Twin Disc's Board approved an amended and restated 2021 Omnibus Incentive Plan, increasing authorized shares by 700,000 to 2,336,550, and set fiscal 2027 base salaries and bonus targets for named executive officers. CEO John H. Batten received a 4% salary increase to $740,554 with a 100% target bonus, and CFO Jeffrey S. Knutson received a 4% increase to $454,480 with a 60% target bonus. The plan is subject to shareholder approval at the next annual meeting; if not approved by August 5, 2027, the prior plan remains in effect.
- · The Omnibus Plan amendment increases authorized shares from 1,636,550 to 2,336,550.
- · The CIP weights: net sales (20%), EBITDA as % of net sales (40%), operating cash flow (20%), corporate growth and profitability (10%), individual performance (10%).
- · Performance stock awards vest based on three-year period ending June 30, 2029, with metrics: average return on invested capital (50%) and cumulative EBITDA (50%).
- · Restricted stock awards vest in three years subject to continued employment.
- · CEO may adjust NEO incentive payments by up to 20% (except his own, which is adjusted by the Committee).
11-08-2026
JBS N.V. reported a 14% increase in net sales to $23.9 billion for Q2 2026, but saw a net loss of $102 million compared to net income of $528 million in the prior year. IFRS Adjusted EBITDA declined 18% driven by lower poultry margins and higher cattle costs, while leverage increased to 3.1x from 2.27x a year ago. The company also announced plant closures, a business unit merger, and increased its revolving credit facility to $4.2 billion.
- · JBS Beef North America Adjusted EBITDA improved to -$78 million vs -$233 million a year ago but remains negative.
- · Pilgrim's Pride net sales declined 2.8% to $4,623M, with gross profit down 34.3%.
- · JBS Brazil recorded record second-quarter net sales of $4,585M, up 28.0% YoY.
- · Seara sales grew 18.2% to $2,560M, but Adjusted EBITDA margin contracted to 14.9% from 18.1%.
- · JBS Australia net sales grew 30.0% to $2,565M, but Adjusted EBITDA fell 20.5% due to 24% higher cattle costs.
- · JBS USA Pork Adjusted EBITDA plunged 54.0% to $117M as domestic demand softened.
- · Non-recurring items in net income included $172M in tender offer costs, $133M in antitrust settlements, and $81M bargain purchase gain.
- · The company joined the Russell 1000 and Russell 3000 indices in Q2 2026.
- · The Company closed two plants (Souderton, PA and Memphis, TN) and merged three beef units into Beef USA.
11-08-2026
Azenta, Inc. appointed Erik J. Bello as Vice President, Chief Accounting Officer, effective August 31, 2026. Mr. Bello will receive an annual base salary of $380,000, a one-time sign-on bonus of $80,000, and long-term incentive awards totaling $450,000 over two fiscal years. Lawrence Lin will cease to serve as principal accounting officer but will continue as Executive Vice President and Chief Financial Officer.
- · Mr. Bello's sign-on bonus of $80,000 is subject to repayment if he voluntarily terminates employment within one year of hire.
- · Mr. Bello holds a B.S. in Accounting from the University of Maryland and is a certified public accountant.
- · There are no family relationships between Mr. Bello and any director or executive officer, and no reportable transactions under Item 404(a) of Regulation S-K.
11-08-2026
CVRx announced the departure of Chief Revenue Officer Robert John, effective immediately, and the appointment of Paul Verrastro as Interim Head of Sales. The change is driven by the company's revised commercial outlook and need to improve execution, reflecting ongoing challenges in sales performance.
- · Paul Verrastro has over 30 years of medical device sales and marketing experience and has been with CVRx for over five years.
- · Verrastro previously served as Chief Marketing and Strategy Officer before moving to a senior advisor role.
- · The company is conducting a search for a permanent successor to the Chief Revenue Officer position.
11-08-2026
Immunic, Inc. appointed Elena Ridloff, CFA to its Board of Directors effective August 6, 2026. Ms. Ridloff brings over 20 years of financial and capital markets experience, having served as CFO at ACADIA Pharmaceuticals and currently as CFO at Sionna Therapeutics. The appointment comes as the company approaches a pivotal Phase 3 ENSURE readout in relapsing multiple sclerosis, with top-line data expected by year-end 2026, and plans to initiate a confirmatory Phase 3 program in progressive MS later in 2026.
- · Elena Ridloff currently serves as CFO at Sionna Therapeutics and also serves on the Board of Directors of Kymera Therapeutics, where she chairs the Audit Committee.
- · She previously served as EVP and CFO of ACADIA Pharmaceuticals, where she raised $600 million in capital.
- · Earlier in her career, she established and led the investor relations function at Alexion Pharmaceuticals, was CEO of BIOVISIO, and served as a Managing Director at Maverick Capital.
- · Vidofludimus calcium combines neuroprotective effects as a first-in-class Nurr1 activator with anti-inflammatory and anti-viral effects by selectively inhibiting DHODH.
- · The company's pipeline also includes earlier-stage programs IMU-381 and IMU-856.
11-08-2026
Aura Biosciences reported Q2 2026 results with net loss widening to $45.6M from $27.0M YoY, driven by increased R&D and G&A expenses, including stock-based compensation from executive transitions. The company fully enrolled its Phase 3 CoMpass trial (108 patients, exceeding target) and extended cash runway into 1H 2029 through a 20% workforce reduction and strategic refocus on ocular oncology, while deprioritizing its NMIBC program despite encouraging interim data. Leadership changes include new COO, Chief Regulatory and Quality Officer, and Chief People Officer, with CFO, CLO, and CTO stepping down.
- · Phase 3 CoMpass trial topline data expected in 2H 2027.
- · NMIBC program deprioritized; data collection through 12-month follow-up to be completed.
- · Restructuring charges estimated at $2.9M to $3.2M, substantially complete by end of Q3 2026.
- · Cash runway extended into 1H 2029.
- · New executives appointed: Susan Abu-Absi (COO), Erica Kratz (Chief Regulatory and Quality Officer), Julie Person (Chief People Officer).
- · CFO, CLO, and CTO stepping down.
- · NMIBC interim data: 81% objective response rate, 69% complete response rate at 3 months; 100% disease-free at 9- or 12-month timepoints.
- · All treatment-related adverse events in NMIBC were Grade 1, no dose-limiting toxicities, no serious adverse events.
- · Additional ocular oncology programs (metastases to choroid, ocular surface cancers) to provide updates in Q1 2027.
11-08-2026
Littelfuse appointed Todd Kelsey, President and CEO of Plexus Corp., to its board of directors and the Compensation Committee. Kelsey brings extensive global technology, engineering, and manufacturing expertise, as well as public company board experience. No financial metrics or performance data were disclosed in this filing.
- · Kelsey was also appointed to the Compensation Committee.
- · Kelsey has served as Vice Chair of the Board and Audit Committee Chair for Steelcase Inc.
- · Kelsey currently serves as Vice Chair of the Board for Wisconsin Manufacturers and Commerce.
- · Kelsey holds bachelor's and master's degrees in electrical engineering from the University of Wisconsin-Madison and an MBA from the University of Wisconsin-Oshkosh.
11-08-2026
ClearSign Technologies announced the appointment of Larry Saddler, a retired ExxonMobil executive with nearly 40 years of experience, to its Board of Directors. Saddler's expertise in heat transfer technology and emissions reduction is expected to support the company's strategic growth and technology adoption. The appointment fills a vacant directorship and is seen as a positive addition to the board.
- · Larry Saddler retired from ExxonMobil in 2021 after a career spanning the US, Thailand, and the UK.
- · He served as Global Technology Sponsor for Heat Transfer at ExxonMobil.
- · He played a key role in advancing next-generation Ultra-Low NOx burner technology.
- · He holds a Bachelor of Science in Mechanical Engineering from Clemson University.
11-08-2026
WEC Energy Group announced the appointment of Caroline Garcia as Vice President and Controller, effective August 31, 2026, succeeding William J. Guc who will retire in early 2027. Ms. Garcia, age 50, brings extensive experience from TXNM Energy and KPMG LLP. Her annual base salary will be $335,000 with short-term and long-term incentive targets of 50% and 70% of base salary, respectively.
- · Ms. Garcia has been serving as Director of Audit Services at TXNM Energy since 2024.
- · Prior to TXNM Energy, she was an Audit Partner at KPMG LLP from 1999 to 2024, focusing on energy, utility, and natural resources sectors.
- · Ms. Garcia is a Certified Public Accountant.
- · Her first long-term incentive awards will be effective with the 2027 award cycle.
- · William J. Guc will assume the role of special advisor to the CFO effective August 31, 2026, to ensure a smooth transition.
11-08-2026
Simon Fisk resigned as Vice President of Fidelity Core Real Estate Fund and as a director and Vice President of its sole trustee, effective September 30, 2026, with no disagreement related to operations, policies, or practices. Vipul Gautam was appointed to succeed him in all roles, effective the same date. The filing is a routine officer change with no financial impact disclosed.
- · The resignation is effective September 30, 2026.
- · Vipul Gautam, 42, currently serves as Head of Direct Real Estate and Private Equity Multi-Strat Product and Investment Services at Fidelity.
- · Gautam previously held roles at Fidelity Institutional Wealth Advisor LLC and Fidelity's Workplace Investing division from 2016 to 2022, and at Morgan Stanley & Co. (2013-2016) and Bank of America Merrill Lynch (2009-2013).
- · No family relationships or reportable transactions exist between Gautam and the company or its officers.
- · The registrant is an emerging growth company.
11-08-2026
Mineralys Therapeutics reported a net loss of $241.1M for Q2 2026, compared to a net loss of $43.3M in Q2 2025, driven largely by a $200.0M upfront payment to Tanabe to eliminate royalty obligations. The company strengthened its balance sheet with a $150.0M public offering and a $500.0M senior secured term loan facility, and appointed Dr. Terry Ferguson as Chief Medical Officer. The PDUFA target date for lorundrostat is December 22, 2026, with commercial preparations on track.
- · Net loss per share for Q2 2026 was $2.85, compared to $0.66 for Q2 2025.
- · Weighted-average shares outstanding increased from 65.5M in Q2 2025 to 84.7M in Q2 2026.
- · Total assets were $667.9M as of June 30, 2026, compared to $661.8M as of December 31, 2025.
- · Senior secured term loan, net was $97.6M as of June 30, 2026; no such debt existed at December 31, 2025.
- · Total liabilities increased from $15.1M to $116.9M, primarily due to the term loan.
- · Total stockholders' equity decreased from $646.7M to $550.9M, reflecting the net loss.
- · The company expects cash to fund operations into 2028.
- · Lorundrostat has 374-fold selectivity for aldosterone-synthase inhibition versus cortisol-synthase inhibition in vitro, with a half-life of 10-12 hours and 40-70% reduction in plasma aldosterone concentration.
11-08-2026
Burke & Herbert Financial Services Corp. (BHRB) entered into a change in control (CIC) agreement with its Executive Vice President and CFO, Kirtan Parikh, on July 6, 2026. The agreement provides Mr. Parikh with severance benefits—including 24 months of base salary, a lump-sum equal to two times his target annual incentive bonus, and up to 18 months of healthcare premium payments—if a change in control occurs and his employment is terminated without cause or for good reason within a specified window. The filing contains no financial results or period-over-period comparisons.
- · CIC benefits triggered if termination occurs within a window from three months before the change in control to 12 months after closing.
- · Severance subject to a separation and release agreement with non-disparagement, cooperation, and non-solicitation clauses.
- · The full CIC Agreement will be filed as an exhibit to the Company's Form 10-Q for the quarter ended September 30, 2026.
11-08-2026
Smart Sand, Inc. reported record second-quarter 2026 results with revenue of $115.1M (up 24% sequentially and 34% YoY) and net income of $10.2M, reversing a net loss of $(3.9)M in Q1 2026. However, free cash flow was negative $(1.4)M in the quarter due to higher capital expenditures, though management expects positive free cash flow for the full year. The company also announced a leadership transition, with James Young becoming CFO effective January 1, 2027, replacing Lee Beckelman, who will remain as an advisor.
- · Company expects 2026 sales volume to increase 10% to 20% vs 2025.
- · Full-year 2026 CapEx guided at $15M to $20M, excluding acquisitions and new terminal investments.
- · Company expects to be free cash flow positive for 2026.
- · Cash on hand as of June 30, 2026: $10.2M; undrawn ABL capacity: $30.0M.
- · Share repurchase program approved Feb 23, 2026, for up to $20.0M in shares, effective through April 2, 2028.
- · Board declared a special dividend of $0.10 per share payable Aug 12, 2026 (record July 28, 2026).
- · A prior special dividend of $0.10 per share was paid May 5, 2026.
- · Expanded LNG export capacity and AI data center electricity demand cited as long-term growth drivers for natural gas demand.
- · SmartSand owns mines in Wisconsin and Illinois with access to four Class I rail lines.
- · Interest expense was $0.3M, consistent across all periods.
11-08-2026
Apogee Therapeutics held a special meeting on August 11, 2026, where stockholders voted to approve the merger with AbbVie Inc. (Proposal 1) with 46,508,107 votes for, 3,885 against, and 14,261 abstentions. However, the non-binding advisory compensation proposal (Proposal 2) was rejected by stockholders (19,323,605 for vs. 27,123,259 against). All directors have indicated they will resign effective at the merger's closing, with no disagreements cited.
- · The adjournment proposal (Proposal 3) was not voted on because sufficient votes existed to approve the merger.
- · All seven directors will resign effective at the merger's closing, with no disagreements cited.
- · The compensation proposal was advisory and non-binding; its rejection does not affect merger consummation.
11-08-2026
Thryv Holdings, Inc. replaced its 2026 Short-Term Incentive Plan (STIP) with a new H2 2026 Bridge Plan effective July 1, 2026, following a recently announced restructuring. The Bridge Plan covers a six-month performance period (July 1 – December 31, 2026) with prorated target opportunities at 50% of the original annual targets and updated performance metrics reflecting the company's revised second-half business plan. The change applies to all employees, including Named Executive Officers, and was approved by the Compensation Committee on August 10, 2026.
- · The Bridge Plan performance period is July 1, 2026 through December 31, 2026.
- · Target opportunities under the Bridge Plan are prorated to 50% of the annual target under the 2026 STIP.
- · Performance metrics and weights: EBITDA (25%), Free Cash Flow (25%), SaaS Revenue (25%), Individual Performance (25%).
- · The Bridge Plan supersedes the 2026 STIP and cancels any prior conflicting documents.
- · Eligible employees must be in a STIP-eligible position for a minimum of 90 consecutive days and commence employment on or before September 30, 2026.
- · The Compensation Committee retains sole discretion to set award levels and adjust payouts.
11-08-2026
Accel Entertainment appointed CEO Mark Phelan as a Class 2027 director on the Board effective August 7, 2026, increasing the Board size from 9 to 10 directors. Mr. Phelan will not receive additional compensation for his director role, and his existing CEO compensation arrangements remain unchanged.
- · Mr. Phelan has not been appointed to any Board committee.
- · Mr. Phelan's term expires at the 2027 Annual Meeting of Stockholders.
- · Mr. Phelan is not a party to any arrangement or transaction requiring disclosure under Item 404(a) of Regulation S-K.
11-08-2026
The Hartford announced the election of Priscilla Almodovar, former president and CEO of Fannie Mae, to its Board of Directors, effective September 1, 2026. She will serve on the Finance, Investment and Risk Management Committee and the Audit Committee, bringing expertise in financial services, capital management, and enterprise risk management. The appointment is a routine board refreshment and does not involve any financial metrics or period-over-period comparisons.
- · Almodovar earned a juris doctor from Columbia Law School and a bachelor's degree from Hofstra University.
- · She currently serves on the boards of Realty Income Corp. and Fifth Third Bancorp.
- · The Hartford is headquartered in Hartford, Connecticut and operates under the brand name The Hartford.
11-08-2026
ConocoPhillips announced a planned leadership succession effective September 1, 2026. Andy O'Brien, currently CFO and EVP of Strategy and Commercial, will succeed Ryan Lance as President and CEO and join the board. Ryan Lance will retire as CEO and become Executive Chair in a transitional role. Konnie Haynes-Welsh, currently VP of Finance and Controller, will become SVP and CFO. The filing contains no financial results or quantitative performance data, only organizational changes.
- · Andy O'Brien began his career with Conoco in 1997 and joined the executive leadership team in 2022.
- · Ryan Lance has served as CEO for 14 years and has a 42-year career with the company.
- · Konnie Haynes-Welsh joined ConocoPhillips in 2012 and previously held roles at PricewaterhouseCoopers and Mariner Energy.
- · The appointments are effective September 1, 2026.
11-08-2026
Radian Group Inc. appointed Barry C. McCarthy, President and CEO of Deluxe Corporation, to its Board of Directors effective August 10, 2026. McCarthy brings extensive experience in payments, financial technology, and data analytics, which aligns with Radian's evolution as a global multi-line specialty insurer. The appointment is a routine board expansion and does not involve any financial metrics or performance changes.
- · Barry C. McCarthy, age 62, is President, CEO and board member of Deluxe Corporation (NYSE-listed Fortune 1000).
- · McCarthy has nearly four decades of executive leadership experience across payments, financial technology, financial services, software, data and analytics, and consumer products.
- · He holds an MBA from the Kellogg School of Management at Northwestern University and is an NACD and ACCD Certified Director.
- · The appointment is effective as of August 10, 2026.
11-08-2026
SES AI Corp filed an 8-K on August 11, 2026, reporting results of operations and financial condition (Item 2.02), a departure of directors or certain officers (Item 5.02), and financial statements and exhibits (Item 9.01). The filing does not disclose specific financial figures or the name of the officer involved, limiting quantitative analysis. The leadership change may signal governance or strategic shifts, but without details, the market impact is uncertain.
11-08-2026
NeoGenomics announced that Alicia Olivo, EVP, General Counsel & Business Development, will transition from her role and cease to serve as General Counsel effective September 21, 2026. She will remain an employee until October 2, 2026 for transitional purposes and will receive separation payments and benefits per her employment agreement. The departure is a senior leadership change with no financial impact disclosed.
- · Ms. Olivo's departure is effective September 21, 2026, with employment ending October 2, 2026.
- · Separation benefits are consistent with Section 5(b) of her employment agreement, referenced in the 2025 Form 10-K filed February 17, 2026.
11-08-2026
Alamo Group Inc. announced the retirement of Edward T. Rizzuti, Executive Vice President and Head of Corporate Development, effective September 11, 2026. The retirement is amicable with no disagreement over operations or financial reporting. The Company entered into a consulting agreement with Mr. Rizzuti from September 14, 2026, to December 31, 2026, at $20,000 per month plus expense reimbursement for advisory support on corporate development initiatives.
- · Consulting agreement runs from September 14, 2026, to December 31, 2026.
- · Mr. Rizzuti's retirement is not due to any disagreement with the Company's operations, financial reporting, or accounting practices.
- · Consulting covers advice on acquisitions, divestitures, and similar corporate development matters.
11-08-2026
Blend Labs, Inc. announced the resignation of Oxana Tkach, Head of Accounting and FP&A (principal accounting officer), effective August 31, 2026, to pursue another opportunity. Jason Ream, Head of Finance and Administration, will serve as interim principal accounting officer without additional compensation. The resignation was not due to any disagreement with auditors or management on accounting matters.
- · Resignation effective on or around August 31, 2026
- · Company has initiated a search for a successor principal accounting officer
- · Jason Ream will not receive additional compensation for the interim role
11-08-2026
Kilroy Realty Corporation announced the departure of CFO Jeffrey Kuehling effective August 11, 2026, with Eliott Trencher assuming the CFO and Treasurer roles on an interim basis. The Company reaffirmed its 2026 guidance provided in the Q2 2026 earnings release. As of June 30, 2026, the stabilized portfolio was 77.0% occupied and 81.5% leased, with residential units averaging 95.6% occupancy, but the departure introduces uncertainty in leadership continuity.
- · Jeffrey Kuehling's departure is not due to disagreements over financial policies, accounting principles, or financial statements/disclosures.
- · The company has retained Russell Reynolds Associates to conduct a CFO search.
- · Eliott Trencher previously served as CFO from 2022 to 2024 and as CIO since 2020.
- · The company reaffirmed 2026 guidance from the July 27, 2026, Q2 earnings release.
11-08-2026
NRC Health (NRC) announced the resignation of CFO Shane Harrison, effective August 28, 2026, to pursue an outside opportunity. The company has initiated a search for a new CFO. This leadership change may create temporary uncertainty, though it is not accompanied by any financial results or strategic shifts.
- · Resignation was tendered on August 7, 2026.
- · Effective date of resignation is August 28, 2026.
- · The resignation is not due to a disagreement with the company.
11-08-2026
Agenus Inc. appointed Marco Tullio Marcucci as a Class II director on August 5, 2026, expanding the board from six to seven members. Mr. Marcucci, an Italian attorney with extensive legal and capital markets experience, will also serve on the Corporate Governance and Nominating Committee. He will receive an annual cash retainer of $75,000, a committee retainer of $7,500, and an option to purchase 7,500 shares vesting over three years.
- · Mr. Marcucci is an attorney based in Rome, Italy, admitted to the Bar Association of Rome since 2002 and to the Special Bar Association of the Supreme Court and High Courts since 2018.
- · The option to purchase 7,500 shares vests in three equal annual installments beginning August 5, 2027, subject to continued service.
- · No arrangement or understanding exists for Mr. Marcucci's appointment, and no family relationships or material interests in transactions were disclosed.
11-08-2026
Gaxos.ai Inc. held its 2026 annual meeting on August 11, 2026, where shareholders approved an amendment to the 2022 Omnibus Equity Incentive Plan to increase reserved shares from 803,637 to 1,000,000, and granted the board authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-50 by August 11, 2028. All four director nominees (Vadim Mats, Adam Holzer, Scott Grayson, Roman Feldman) were elected, and Salberg & Company, P.A. was ratified as independent auditor for FY2026. Notably, the reverse stock split proposal passed with 63% of votes cast in favor, while the plan amendment received only 76% of non-broker votes in favor, indicating some shareholder dissent.
- · Reverse stock split authority expires August 11, 2028.
- · Broker non-votes were 4,039,445 on director elections and the plan amendment, but zero on auditor ratification and reverse split proposal.
- · Auditor ratification passed with 4,585,107 for, 245,714 against, 39,121 abstain.
- · The plan amendment received 630,447 for, 197,790 against, 2,260 abstain (excluding broker non-votes).
- · Reverse split proposal: 3,068,168 for, 1,754,234 against, 47,540 abstain.
11-08-2026
Matthews International Corporation announced the appointment of Michael J. Whitehead as President and CEO, succeeding Joseph C. Bartolacci who is retiring after over 20 years. Whitehead, a former Lincoln Electric executive, brings extensive experience in industrial technology, innovation, and operational excellence. The company remains focused on executing strategic priorities and creating long-term value, though no specific financial guidance or performance metrics were provided in the filing.
- · Whitehead holds a Bachelor of Science in Electrical Engineering from The Ohio State University and a Juris Doctor from the University of New Hampshire School of Law.
- · Whitehead is an electrical engineer and patent attorney.
- · Whitehead joined Lincoln Electric in 2005 as Chief Counsel, Intellectual Property.
- · Matthews International operates through two core global businesses: Industrial Technologies and Memorialization.
- · The company also has a significant investment in Propelis, a brand solutions business.
- · Matthews has over 4,300 employees in 15 countries on four continents.
11-08-2026
B&G Foods announced the retirement of CEO Kenneth C. “Casey” Keller, effective August 7, 2026, after five years in the role. The Board has selected a successor who currently serves as a senior leader at another public company, but his identity has not yet been disclosed pending coordination with his current employer. The outgoing CEO and Board Chair highlighted portfolio reshaping efforts through recent divestitures and acquisitions, but the company faces ongoing industry headwinds including supply chain disruption, price inflation, and tariffs.
- · The successor CEO has accepted the offer but his identity is withheld at his request.
- · B&G Foods expects to announce the incoming CEO shortly in coordination with the successor's current employer's reporting requirements.
- · Mr. Keller will assist in the leadership transition on an ongoing basis after his retirement date.
- · The company has a pending divestiture of its Green Giant and Le Sieur frozen and shelf-stable business in Canada.
- · Recent acquisition includes College Inn and Kitchen Basics.
11-08-2026
Imunon, Inc. announced compensatory programs for certain executive officers, allowing them to elect to receive a portion of their base salary in common stock, with additional shares issuable. The programs cover CEO Stacy Lindborg (up to 50% of salary), Executive Chairman Michael Tardugno (up to 100%), and CMO Douglas Faller (up to 40%). The shares are issued under exemptions or the 2018 Stock Incentive Plan.
- · Shares issued to Dr. Lindborg and Mr. Tardugno are exempt from registration under Section 4(a)(2) of the Securities Act.
- · Shares issued to Dr. Faller will be issued pursuant to the Imunon, Inc. 2018 Stock Incentive Plan, as amended and restated.
11-08-2026
Group 1 Automotive appointed David C. Kimbell, former CEO of Ulta Beauty, to its Board of Directors effective August 10, 2026, increasing the board from nine to ten members. Mr. Kimbell will serve on the Audit Committee and brings over 30 years of retail and digital transformation experience. The appointment is a positive governance move but does not involve any financial results or operational changes.
- · Mr. Kimbell holds a B.A. in Economics and Management from DePauw University and an M.B.A. from Purdue University.
- · He currently serves on the Board of Best Buy Co., Inc.
- · During his tenure as CEO of Ulta Beauty, revenue increased from $6.2 billion in 2020 to $11.3 billion.
- · Group 1 Automotive operates 249 dealerships, 310 franchises, and 32 collision centers in the U.S. and U.K., offering 37 brands.
11-08-2026
Lee Enterprises approved one-time transition equity awards for CEO Nathan E. Bekke ($1.75M target) and CFO Joshua P. Rinehults ($900K target) on August 6, 2026, following the February 2026 transaction and leadership transition. The awards consist of 50% performance stock units and 50% restricted stock, with performance stock units tied 50% to stock price and 50% to Adjusted EBITDA over a period ending September 2028, and restricted stock vesting in three equal annual installments. Additionally, the Committee approved a revised annual long-term incentive framework under the LTIP, with target award values of 300% of base compensation for the CEO, 225% for the CFO, and 175% for the Chief Revenue Officer, comprising 40% restricted stock, 40% performance stock units, and 20% stock options.
- · Transition awards are one-time awards separate from annual LTIP.
- · Performance stock units have a performance period ending September 2028.
- · Committee retains authority to adjust performance calculations for certain significant corporate events.
- · Restricted stock awards vest in three equal annual installments subject to continued service.
- · Revised annual LTIP framework applies to CEO, CFO, and Chief Revenue Officer.
- · Annual performance stock units under revised framework also based 50% on stock price and 50% on Adjusted EBITDA over three-year period, with 0%-200% payout range.
- · Annual restricted stock vests ratably over three years.
11-08-2026
Inuvo reported Q2 2026 results with Audience Modeling revenue growing 19% YoY, but total net revenue fell 67% to $7.5 million due to an 80% decline in Legacy Search revenue. Net loss widened to $4.0 million ($0.27 per share) from $1.5 million ($0.10 per share) a year earlier, and Adjusted EBITDA loss increased to $1.8 million from $0.6 million. The company strengthened its balance sheet with ~$13 million in financing, retired prior debt, and added working capital, but cash and equivalents fell to $886 thousand. Operating expenses decreased 67% to $6.4 million, while operating loss grew to $3.0 million from $2.0 million.
- · Added five new brand-direct relationships, including two Fortune Global 500 companies.
- · Expanded IntentKey applications beyond traditional consumer advertising.
- · Completed financing transactions totaling ~$13 million, with $10.3 million from secured promissory notes and $3.0 million from a registered direct offering of common stock and pre-funded warrants.
- · Retired prior convertible promissory note and receivables-based credit facility by June 30, 2026.
- · Incurred a $0.9 million charge for debt extinguishment.
- · Operating loss increased to $3.0 million from $2.0 million in Q2 2025; Adjusted EBITDA loss widened to $1.8 million from $0.6 million.
- · Cash and cash equivalents fell to $886K as of June 30, 2026 (excluding $3.0 million received in July).
- · Total stockholders' equity decreased 17% from December 31, 2025 to $8.3 million.
11-08-2026
Butterfly Network, Inc. announced that Dr. Erica Schwartz has stepped down from its Board of Directors effective August 5, 2026, following her confirmation as Director of the CDC. The company congratulated her on the appointment and noted her service since 2021. No financial impact or replacement was disclosed.
- · Dr. Schwartz served on the Board since 2021.
- · Her resignation was effective August 5, 2026.
- · No successor or interim replacement was announced.
- · The company filed a separate Form 8-K with additional transition details.
11-08-2026
ManpowerGroup announced the appointment of John B. Gibson Jr., President and CEO of Paychex, to its Board of Directors effective September 1, 2026. Gibson brings deep experience in human capital management and technology-enabled services, having led Paychex's largest-ever acquisition of Paycor in April 2025. The appointment strengthens the board's strategic and operational expertise as ManpowerGroup advances its transformation strategy.
- · Gibson has served as President and CEO of Paychex since October 2022.
- · He led Paychex's acquisition of Paycor in April 2025, the largest in the company's history.
- · Previously, from 2020 to 2022, Gibson was Paychex's President and COO.
- · He joined Paychex in 2013 as Senior Vice President of Service.
- · Gibson holds a Bachelor of Arts degree from Indiana University and completed executive education at Northwestern University's Kellogg School of Management and INSEAD.
- · ManpowerGroup operates in more than 70 countries and has been in business for over 75 years.
- · In 2026, ManpowerGroup was named one of the World's Most Ethical Companies for the 17th time.
11-08-2026
Stardust Power Inc. appointed V. Ray Rivers to its Board of Directors effective August 10, 2026; he will also serve on the Audit Committee and Compensation Committee. Rivers brings more than three decades of capital-markets, institutional-investment, financial-services, and public-company governance experience, while the filing contains no financial results or period-over-period operating metrics.
- · Stardust Power's refinery is being developed in Muskogee, Oklahoma.
- · The company describes the refinery as one of America's largest planned battery-grade lithium carbonate refineries.
- · V. Ray Rivers currently serves as Co-Chair of the Greenwich Economic Forum.
- · The filing identifies macroeconomic conditions, inflationary pressures, interest-rate changes, supply-chain disruptions, regulatory or legal changes, litigation exposure, cybersecurity threats, and foreign-exchange fluctuations as risks to forward-looking statements.
- · The appointment was disclosed in an August 11, 2026 Form 8-K under Items 5.02 and 9.01.
11-08-2026
Regions Financial announced the retirement of Chief Administrative Officer Dave Keenan at the end of 2026, with Kate Danella succeeding him. John Jordan will become head of Consumer Banking, and Chief People Officer Angela Santone will report directly to CEO John Turner. The leadership transition is part of the company's talent planning and is expected to be seamless.
- · Dave Keenan has served as Chief Administrative Officer since 2020 and previously led Human Resources for 10 years.
- · Keenan joined AmSouth (predecessor) in 2003.
- · Kate Danella joined Regions in 2015 and led Consumer Banking since 2022.
- · John Jordan joined Regions in 2024 from Bank of America, where he spent over 20 years.
- · Angela Santone joined Regions in 2025 with experience from Turner Broadcasting System and AT&T.
- · Keenan will move to a leadership advisory role starting Sept. 1, 2026, until retirement at end of 2026.
- · Regions operates in 15 states across the South, Midwest, and Texas.
11-08-2026
Lincoln Electric Holdings announced that Michael J. Whitehead, Executive Vice President and President of Americas Welding, will resign effective August 28, 2026 to pursue other business opportunities. His departure is not related to any disagreement with the company. In the interim, Americas Welding will be jointly led by Gary Konarska and Albert Castillo until a successor is named.
- · Resignation effective date: August 28, 2026
- · Interim leadership: Gary Konarska and Albert Castillo jointly leading Americas Welding
- · No disagreement with company, board, or management cited
11-08-2026
Embassy Bancorp, Inc. announced the passing of Director John G. Englesson on August 7, 2026. Mr. Englesson had served on the board since the company's formation in 2008 and on the board of its primary operating subsidiary since 2001. The filing does not contain any financial data or period-over-period comparisons.
- · Mr. Englesson was one of the principal owners of Chadwick Telecommunications Corporation and the 'Chadwick Family' of Companies.
- · He volunteered with numerous community organizations including Allentown Economic Development Corporation, Bethlehem Economic Development Corporation, Lehigh Valley Economic Development Corporation, Rotary Club of Bethlehem, and the American Hellenic Educational Progressive Association.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 40 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
August 07, 2026
US Executive Officer Management Changes SEC — August 07, 2026
August 06, 2026
US Executive Officer Management Changes SEC — August 06, 2026
August 05, 2026
US Executive Officer Management Changes SEC — August 05, 2026
August 04, 2026
US Executive Officer Management Changes SEC — August 04, 2026
🇺🇸 More from United States
View all →August 12, 2026
US Pre-Market SEC Filings Roundup — August 12, 2026
US Pre-Market SEC Filings Roundup
August 12, 2026
USA Corporate Events Calendar — August 12, 2026
USA Corporate Events Calendar
August 12, 2026
USA Earnings Calls Schedule — August 12, 2026
USA Earnings Calls Schedule
August 12, 2026
US Corporate Board Director Changes SEC Filings — August 12, 2026
US Corporate Board Director Changes SEC Filings